| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T0 |
0-10 |
MPA |
denotes |
Conversion |
| T1 |
14-23 |
MPA |
denotes |
sirolimus |
| T2 |
27-42 |
DISEASE |
denotes |
kidney-pancreas |
| T3 |
95-104 |
MPA |
denotes |
sirolimus |
| T4 |
106-109 |
MPA |
denotes |
SRL |
| T5 |
149-156 |
NEGREG |
denotes |
limited |
| T6 |
211-225 |
MPA |
denotes |
SRL conversion |
| T7 |
302-317 |
DISEASE |
denotes |
kidney-pancreas |
| T8 |
370-379 |
REG |
denotes |
converted |
| T9 |
383-386 |
MPA |
denotes |
SRL |
| T10 |
404-414 |
MPA |
denotes |
conversion |
| T11 |
449-463 |
MPA |
denotes |
nephrotoxicity |
| T12 |
449-463 |
DISEASE |
denotes |
nephrotoxicity |
| T13 |
479-485 |
POSREG |
denotes |
severe |
| T14 |
486-499 |
MPA |
denotes |
neurotoxicity |
| T15 |
486-499 |
DISEASE |
denotes |
neurotoxicity |
| T16 |
500-505 |
REG |
denotes |
owing |
| T17 |
509-512 |
MPA |
denotes |
CNI |
| T18 |
526-532 |
POSREG |
denotes |
severe |
| T19 |
540-549 |
REG |
denotes |
recurrent |
| T20 |
550-565 |
DISEASE |
denotes |
acute rejection |
| T21 |
589-605 |
DISEASE |
denotes |
gastrointestinal |
| T22 |
650-653 |
MPA |
denotes |
MMF |
| T23 |
672-685 |
MPA |
denotes |
hyperglycemia |
| T24 |
672-685 |
DISEASE |
denotes |
hyperglycemia |
| T25 |
707-717 |
MPA |
denotes |
conversion |
| T26 |
737-747 |
REG |
denotes |
maintained |
| T27 |
753-756 |
MPA |
denotes |
CNI |
| T28 |
758-761 |
MPA |
denotes |
MMF |
| T29 |
776-784 |
MPA |
denotes |
steroids |
| T30 |
806-815 |
REG |
denotes |
converted |
| T31 |
819-822 |
MPA |
denotes |
SRL |
| T32 |
823-833 |
REG |
denotes |
associated |
| T33 |
846-849 |
MPA |
denotes |
CNI |
| T34 |
853-867 |
MPA |
denotes |
MMF withdrawal |
| T35 |
919-928 |
REG |
denotes |
converted |
| T36 |
938-956 |
MPA |
denotes |
CNI nephrotoxicity |
| T37 |
938-956 |
DISEASE |
denotes |
CNI nephrotoxicity |
| T38 |
958-964 |
REG |
denotes |
showed |
| T39 |
965-971 |
POSREG |
denotes |
stable |
| T40 |
975-983 |
POSREG |
denotes |
improved |
| T41 |
984-998 |
CPA |
denotes |
renal function |
| T42 |
1019-1029 |
MPA |
denotes |
conversion |
| T43 |
1037-1054 |
MPA |
denotes |
creatinine levels |
| T44 |
1074-1083 |
NEGREG |
denotes |
decreased |
| T45 |
1147-1163 |
MPA |
denotes |
C-peptide values |
| T46 |
1164-1173 |
POSREG |
denotes |
increased |
| T47 |
1245-1264 |
DISEASE |
denotes |
leucoencephalopathy |
| T48 |
1265-1271 |
REG |
denotes |
showed |
| T49 |
1272-1280 |
POSREG |
denotes |
improved |
| T50 |
1281-1298 |
CPA |
denotes |
neurologic status |
| T51 |
1305-1319 |
MPA |
denotes |
SRL conversion |
| T52 |
1334-1343 |
REG |
denotes |
converted |
| T53 |
1347-1350 |
MPA |
denotes |
SRL |
| T54 |
1362-1377 |
MPA |
denotes |
GI side effects |
| T55 |
1381-1384 |
MPA |
denotes |
MMF |
| T56 |
1385-1391 |
REG |
denotes |
showed |
| T57 |
1392-1404 |
POSREG |
denotes |
improvements |
| T58 |
1410-1414 |
NEGREG |
denotes |
none |
| T59 |
1424-1433 |
REG |
denotes |
converted |
| T60 |
1445-1458 |
MPA |
denotes |
hyperglycemia |
| T61 |
1445-1458 |
DISEASE |
denotes |
hyperglycemia |
| T62 |
1459-1470 |
REG |
denotes |
experienced |
| T63 |
1471-1482 |
POSREG |
denotes |
improvement |
| T64 |
1498-1506 |
REG |
denotes |
episodes |
| T65 |
1510-1525 |
DISEASE |
denotes |
acute rejection |
| T66 |
1532-1542 |
MPA |
denotes |
conversion |
| T67 |
1562-1572 |
MPA |
denotes |
conversion |
| T68 |
1576-1579 |
MPA |
denotes |
SRL |
| T69 |
1681-1699 |
MPA |
denotes |
CNI nephrotoxicity |
| T70 |
1681-1699 |
DISEASE |
denotes |
CNI nephrotoxicity |
| T71 |
1704-1717 |
MPA |
denotes |
neurotoxicity |
| T72 |
1704-1717 |
DISEASE |
denotes |
neurotoxicity |
| T73 |
1735-1741 |
POSREG |
denotes |
severe |
| T74 |
1742-1750 |
MPA |
denotes |
diarrhea |
| T75 |
1742-1750 |
DISEASE |
denotes |
diarrhea |
| T76 |
1751-1754 |
REG |
denotes |
due |
| T77 |
1755-1757 |
REG |
denotes |
to |
| T78 |
1758-1761 |
MPA |
denotes |
MMF |
| R0 |
T1 |
T0 |
ThemeOf |
sirolimus,Conversion |
| R1 |
T3 |
T5 |
ThemeOf |
sirolimus,limited |
| R10 |
T20 |
T18 |
ThemeOf |
acute rejection,severe |
| R11 |
T20 |
T19 |
ThemeOf |
acute rejection,recurrent |
| R12 |
T25 |
T26 |
ThemeOf |
conversion,maintained |
| R13 |
T27 |
T26 |
ThemeOf |
CNI,maintained |
| R14 |
T27 |
T32 |
ThemeOf |
CNI,associated |
| R15 |
T28 |
T26 |
ThemeOf |
MMF,maintained |
| R16 |
T29 |
T26 |
ThemeOf |
steroids,maintained |
| R17 |
T30 |
T32 |
ThemeOf |
converted,associated |
| R18 |
T31 |
T30 |
ThemeOf |
SRL,converted |
| R19 |
T31 |
T32 |
ThemeOf |
SRL,associated |
| R2 |
T4 |
T5 |
ThemeOf |
SRL,limited |
| R20 |
T34 |
T32 |
ThemeOf |
MMF withdrawal,associated |
| R21 |
T33 |
T32 |
ThemeOf |
CNI,associated |
| R22 |
T39 |
T38 |
ThemeOf |
stable,showed |
| R23 |
T40 |
T39 |
ThemeOf |
improved,stable |
| R24 |
T40 |
T38 |
ThemeOf |
improved,showed |
| R25 |
T41 |
T40 |
ThemeOf |
renal function,improved |
| R26 |
T41 |
T38 |
ThemeOf |
renal function,showed |
| R27 |
T41 |
T39 |
ThemeOf |
renal function,stable |
| R28 |
T42 |
T44 |
ThemeOf |
conversion,decreased |
| R29 |
T43 |
T42 |
ThemeOf |
creatinine levels,conversion |
| R3 |
T9 |
T8 |
ThemeOf |
SRL,converted |
| R30 |
T43 |
T44 |
ThemeOf |
creatinine levels,decreased |
| R31 |
T45 |
T44 |
ThemeOf |
C-peptide values,decreased |
| R32 |
T45 |
T46 |
ThemeOf |
C-peptide values,increased |
| R33 |
T47 |
T48 |
ThemeOf |
leucoencephalopathy,showed |
| R34 |
T47 |
T49 |
ThemeOf |
leucoencephalopathy,improved |
| R35 |
T50 |
T49 |
ThemeOf |
neurologic status,improved |
| R36 |
T50 |
T48 |
ThemeOf |
neurologic status,showed |
| R37 |
T51 |
T49 |
ThemeOf |
SRL conversion,improved |
| R38 |
T53 |
T52 |
ThemeOf |
SRL,converted |
| R39 |
T54 |
T56 |
ThemeOf |
GI side effects,showed |
| R4 |
T11 |
T10 |
ThemeOf |
nephrotoxicity,conversion |
| R40 |
T55 |
T54 |
ThemeOf |
MMF,GI side effects |
| R41 |
T55 |
T56 |
ThemeOf |
MMF,showed |
| R42 |
T58 |
T56 |
CauseOf |
none,showed |
| R43 |
T58 |
T57 |
CauseOf |
none,improvements |
| R44 |
T58 |
T62 |
CauseOf |
none,experienced |
| R45 |
T58 |
T63 |
CauseOf |
none,improvement |
| R46 |
T60 |
T59 |
ThemeOf |
hyperglycemia,converted |
| R47 |
T60 |
T62 |
ThemeOf |
hyperglycemia,experienced |
| R48 |
T60 |
T63 |
ThemeOf |
hyperglycemia,improvement |
| R49 |
T63 |
T62 |
ThemeOf |
improvement,experienced |
| R5 |
T13 |
T16 |
ThemeOf |
severe,owing |
| R50 |
T64 |
T66 |
ThemeOf |
episodes,conversion |
| R51 |
T65 |
T64 |
ThemeOf |
acute rejection,episodes |
| R52 |
T65 |
T66 |
ThemeOf |
acute rejection,conversion |
| R53 |
T68 |
T67 |
ThemeOf |
SRL,conversion |
| R54 |
T69 |
T73 |
ThemeOf |
CNI nephrotoxicity,severe |
| R55 |
T71 |
T73 |
ThemeOf |
neurotoxicity,severe |
| R56 |
T71 |
T76 |
ThemeOf |
neurotoxicity,due |
| R57 |
T73 |
T76 |
ThemeOf |
severe,due |
| R58 |
T77 |
T73 |
CauseOf |
to,severe |
| R59 |
T74 |
T73 |
ThemeOf |
diarrhea,severe |
| R6 |
T14 |
T13 |
ThemeOf |
neurotoxicity,severe |
| R60 |
T74 |
T76 |
ThemeOf |
diarrhea,due |
| R61 |
T77 |
T74 |
CauseOf |
to,diarrhea |
| R62 |
T78 |
T73 |
ThemeOf |
MMF,severe |
| R63 |
T78 |
T77 |
ThemeOf |
MMF,to |
| R7 |
T14 |
T16 |
ThemeOf |
neurotoxicity,owing |
| R8 |
T19 |
T18 |
ThemeOf |
recurrent,severe |
| R9 |
T20 |
T13 |
ThemeOf |
acute rejection,severe |
